ICU Medical, Inc. (ICUI) Guidance & Earnings Results

On 2026-08-06 ICU Medical, Inc. raised guidance: "GAAP net income raised from $26M-$44M to $73M-$83M; adjusted EBITDA raised from $400M-$430M to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ICUIICU Medical, Inc.Follow ICUI — free

Medical Instruments & Supplies · Healthcare

—

Price chart with a free account

Market cap: 4.2B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Aug 26	Raised	GAAP net income raised from $26M-$44M to $73M-$83M; adjusted EBITDA raised from $400M-$430M to $415M-$435M · full year
19 Feb 26	Reaffirmed	FY2026 adjusted EBITDA $400-430M, adjusted EPS $7.75-8.45 · full year
6 Nov 25	Raised	Adjusted EBITDA guidance raised to $395-405M from $380-390M; adjusted EPS to $7.35-7.65 from $6.85-7.15 · full year
7 Aug 25	Mixed	FY25 GAAP net loss narrowed to $(43)-$(35)M from $(45)-$(28)M; GAAP diluted loss per share $(1.68)-$(1.38) from $(1.81)-$(1.11); adjusted EBITDA narrowed to $380-390M from $380-405M; adjusted diluted EPS raised to $6.85-7.15 from $6.55-7.25. · full year

ICU Medical, Inc. — questions

What guidance did ICU Medical, Inc. give?: On 2026-08-06: "GAAP net income raised from $26M-$44M to $73M-$83M; adjusted EBITDA raised from $400M-$430M to $415M-$435M"
When does ICU Medical, Inc. report earnings?: ICU Medical, Inc.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from ICU Medical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.